

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 4.15555639 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.15555639 |
| 3 | macrophage activation involved in immune response (GO:0002281) | 3.82205675 |
| 4 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.62745227 |
| 5 | detection of other organism (GO:0098543) | 3.58327353 |
| 6 | detection of bacterium (GO:0016045) | 3.46194924 |
| 7 | germinal center formation (GO:0002467) | 3.35021970 |
| 8 | granulocyte activation (GO:0036230) | 3.31349099 |
| 9 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.28898446 |
| 10 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15731800 |
| 11 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.15063677 |
| 12 | cellular response to type I interferon (GO:0071357) | 3.14919336 |
| 13 | type I interferon signaling pathway (GO:0060337) | 3.14919336 |
| 14 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14299335 |
| 15 | response to type I interferon (GO:0034340) | 3.10978749 |
| 16 | neutrophil activation (GO:0042119) | 3.10387377 |
| 17 | detection of external biotic stimulus (GO:0098581) | 3.09972041 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.07416542 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 3.04642045 |
| 20 | cellular extravasation (GO:0045123) | 3.02277844 |
| 21 | regulation of mast cell degranulation (GO:0043304) | 3.02159829 |
| 22 | defense response to protozoan (GO:0042832) | 2.98259540 |
| 23 | response to protozoan (GO:0001562) | 2.98155578 |
| 24 | myeloid dendritic cell differentiation (GO:0043011) | 2.94231469 |
| 25 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.92506994 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.91761708 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.91761708 |
| 28 | myeloid cell activation involved in immune response (GO:0002275) | 2.88593602 |
| 29 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.86162696 |
| 30 | regulation of podosome assembly (GO:0071801) | 2.85284488 |
| 31 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.83072592 |
| 32 | detection of biotic stimulus (GO:0009595) | 2.81636949 |
| 33 | regulation of chemokine biosynthetic process (GO:0045073) | 2.77065078 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.75834652 |
| 35 | response to host immune response (GO:0052572) | 2.75610814 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75610814 |
| 37 | macrophage activation (GO:0042116) | 2.75004420 |
| 38 | regulation of leukocyte degranulation (GO:0043300) | 2.74808374 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.73340107 |
| 40 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.72420189 |
| 41 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72269630 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71303585 |
| 43 | cellular glucuronidation (GO:0052695) | 2.69634699 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.69311973 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 2.69274464 |
| 46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69115374 |
| 47 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.68394204 |
| 48 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.67816599 |
| 49 | valine metabolic process (GO:0006573) | 2.67387827 |
| 50 | positive regulation of type 2 immune response (GO:0002830) | 2.66655973 |
| 51 | myeloid dendritic cell activation (GO:0001773) | 2.65551283 |
| 52 | response to host (GO:0075136) | 2.65060111 |
| 53 | response to host defenses (GO:0052200) | 2.65060111 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.65060111 |
| 55 | regulation of mononuclear cell migration (GO:0071675) | 2.63566953 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.63108116 |
| 57 | respiratory burst (GO:0045730) | 2.62928645 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.62867384 |
| 59 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.62530542 |
| 60 | low-density lipoprotein particle clearance (GO:0034383) | 2.62268461 |
| 61 | negative regulation of interleukin-6 production (GO:0032715) | 2.61337969 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.60757939 |
| 63 | modulation by symbiont of host cellular process (GO:0044068) | 2.60413114 |
| 64 | regulation of type 2 immune response (GO:0002828) | 2.59828139 |
| 65 | protein localization to endosome (GO:0036010) | 2.57406182 |
| 66 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.56869329 |
| 67 | regulation of necrotic cell death (GO:0010939) | 2.56760806 |
| 68 | regulation of T cell tolerance induction (GO:0002664) | 2.56677642 |
| 69 | T cell apoptotic process (GO:0070231) | 2.55147362 |
| 70 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.54694662 |
| 71 | ribosomal small subunit assembly (GO:0000028) | 2.54530916 |
| 72 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.53541986 |
| 73 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.51439427 |
| 74 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49684624 |
| 75 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.47966880 |
| 76 | purine nucleotide salvage (GO:0032261) | 2.47868034 |
| 77 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47031907 |
| 78 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.46735741 |
| 79 | uronic acid metabolic process (GO:0006063) | 2.46681933 |
| 80 | glucuronate metabolic process (GO:0019585) | 2.46681933 |
| 81 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44994794 |
| 82 | negative regulation of interleukin-12 production (GO:0032695) | 2.44603936 |
| 83 | negative regulation of necroptotic process (GO:0060546) | 2.44069487 |
| 84 | neutrophil mediated immunity (GO:0002446) | 2.43916769 |
| 85 | regulation of interleukin-6 production (GO:0032675) | 2.43839502 |
| 86 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.43801780 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.42080094 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 2.40367548 |
| 89 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.35514925 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.35481983 |
| 91 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.34919568 |
| 92 | protein carboxylation (GO:0018214) | 2.34919568 |
| 93 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.33692746 |
| 94 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.33085040 |
| 95 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.32119762 |
| 96 | negative regulation of fibrinolysis (GO:0051918) | 2.31347644 |
| 97 | positive regulation of lipid storage (GO:0010884) | 2.29795635 |
| 98 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.29077512 |
| 99 | pinocytosis (GO:0006907) | 2.28057881 |
| 100 | positive regulation of interferon-alpha production (GO:0032727) | 2.27456593 |
| 101 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.26384235 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 2.25721578 |
| 103 | regulation of gamma-delta T cell activation (GO:0046643) | 2.25103183 |
| 104 | AMP metabolic process (GO:0046033) | 2.24591248 |
| 105 | hepatocyte apoptotic process (GO:0097284) | 2.24162194 |
| 106 | fibrinolysis (GO:0042730) | 2.21444253 |
| 107 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.20018687 |
| 108 | primary alcohol catabolic process (GO:0034310) | 2.19568610 |
| 109 | xenobiotic catabolic process (GO:0042178) | 2.18829361 |
| 110 | plasma lipoprotein particle clearance (GO:0034381) | 2.18792524 |
| 111 | negative regulation of cholesterol transport (GO:0032375) | 2.17894496 |
| 112 | negative regulation of sterol transport (GO:0032372) | 2.17894496 |
| 113 | leukocyte aggregation (GO:0070486) | 2.17746445 |
| 114 | lymphocyte apoptotic process (GO:0070227) | 2.17499951 |
| 115 | regulation of interferon-alpha production (GO:0032647) | 2.17485260 |
| 116 | response to muramyl dipeptide (GO:0032495) | 2.16724904 |
| 117 | response to nitrosative stress (GO:0051409) | 2.16645324 |
| 118 | response to peptidoglycan (GO:0032494) | 2.16200874 |
| 119 | sulfur amino acid catabolic process (GO:0000098) | 2.15178212 |
| 120 | regulation of cholesterol storage (GO:0010885) | 2.12463620 |
| 121 | aldehyde catabolic process (GO:0046185) | 2.12105992 |
| 122 | glycine metabolic process (GO:0006544) | 2.09815975 |
| 123 | regulation of vitamin metabolic process (GO:0030656) | 2.08903437 |
| 124 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.05813903 |
| 125 | cellular response to virus (GO:0098586) | 2.04466507 |
| 126 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.04130689 |
| 127 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.04130689 |
| 128 | neutrophil activation involved in immune response (GO:0002283) | 2.03747154 |
| 129 | regulation of triglyceride catabolic process (GO:0010896) | 2.03336229 |
| 130 | negative regulation of phagocytosis (GO:0050765) | 2.03194375 |
| 131 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.03182352 |
| 132 | regulation of necroptotic process (GO:0060544) | 2.02413842 |
| 133 | positive regulation of extracellular matrix organization (GO:1903055) | 2.02180964 |
| 134 | nucleotide salvage (GO:0043173) | 2.02112727 |
| 135 | positive regulation of isotype switching (GO:0045830) | 2.01869564 |
| 136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.00313017 |
| 137 | purine-containing compound salvage (GO:0043101) | 1.99777330 |
| 138 | viral transcription (GO:0019083) | 1.99625509 |
| 139 | folic acid metabolic process (GO:0046655) | 1.99391352 |
| 140 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 1.99281042 |
| 141 | positive regulation of blood coagulation (GO:0030194) | 1.99080530 |
| 142 | positive regulation of hemostasis (GO:1900048) | 1.99080530 |
| 143 | wound healing, spreading of epidermal cells (GO:0035313) | 1.98756885 |
| 144 | regulation of cytokine secretion involved in immune response (GO:0002739) | 1.98497542 |
| 145 | modulation by symbiont of host defense response (GO:0052031) | 1.98389381 |
| 146 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 1.98389381 |
| 147 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 1.98389381 |
| 148 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 1.98389381 |
| 149 | modulation by symbiont of host immune response (GO:0052553) | 1.98389381 |
| 150 | positive regulation by symbiont of host defense response (GO:0052509) | 1.98389381 |
| 151 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 1.97497068 |
| 152 | positive regulation of B cell mediated immunity (GO:0002714) | 1.97497068 |
| 153 | leukocyte apoptotic process (GO:0071887) | 1.97427457 |
| 154 | nucleoside salvage (GO:0043174) | 1.97242817 |
| 155 | regulation of natural killer cell differentiation (GO:0032823) | 1.97082491 |
| 156 | B cell mediated immunity (GO:0019724) | 1.96305364 |
| 157 | regulation of response to interferon-gamma (GO:0060330) | 1.95353012 |
| 158 | amino-acid betaine metabolic process (GO:0006577) | 1.95035347 |
| 159 | cysteine metabolic process (GO:0006534) | 1.94592733 |
| 160 | pentose-phosphate shunt (GO:0006098) | 1.94064669 |
| 161 | positive regulation of coagulation (GO:0050820) | 1.93922762 |
| 162 | translational termination (GO:0006415) | 1.93817745 |
| 163 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 1.92874502 |
| 164 | positive regulation of macrophage differentiation (GO:0045651) | 1.92857489 |
| 165 | regulation of metalloenzyme activity (GO:0048552) | 1.92537365 |
| 166 | negative regulation of erythrocyte differentiation (GO:0045647) | 1.92064248 |
| 167 | folic acid transport (GO:0015884) | 1.91948895 |
| 168 | cellular response to nicotine (GO:0071316) | 1.91938219 |
| 169 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 1.91873942 |
| 170 | serine family amino acid biosynthetic process (GO:0009070) | 1.91538399 |
| 171 | regulation of plasminogen activation (GO:0010755) | 1.91213443 |
| 172 | urea cycle (GO:0000050) | 1.89808925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.55657020 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.27919630 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.13446236 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.91595854 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.70714408 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62030217 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.54971727 |
| 8 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.50200255 |
| 9 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.50143146 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.47606923 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.38712568 |
| 12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08771492 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.05166799 |
| 14 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03451547 |
| 15 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.00075645 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.95893288 |
| 17 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91548620 |
| 18 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.90493623 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87869224 |
| 20 | * MYC_22102868_ChIP-Seq_BL_Human | 1.87659398 |
| 21 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83548505 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.83196597 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.81904654 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81141926 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78002742 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77738327 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.74776176 |
| 28 | GATA1_19941826_ChIP-Seq_K562_Human | 1.73645399 |
| 29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69398068 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67582779 |
| 31 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.67178416 |
| 32 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.67112394 |
| 33 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66090743 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64595287 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64523889 |
| 36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63436403 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62932985 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61547572 |
| 39 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60257448 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57695975 |
| 41 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57008570 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55214158 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.54735961 |
| 44 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53930788 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51846183 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51608148 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.51393200 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49762522 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48527492 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47629682 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.45463166 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44781866 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43961971 |
| 54 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43746284 |
| 55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38894286 |
| 56 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38816848 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38180760 |
| 58 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.35802813 |
| 59 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35632612 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35247205 |
| 61 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33414433 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33354345 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31099595 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30898643 |
| 65 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29919631 |
| 66 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.29704093 |
| 67 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28991569 |
| 68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28823865 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.28439710 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27957534 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27852757 |
| 72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27184748 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26551158 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26352044 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25939517 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25530662 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24542640 |
| 78 | MYB_26560356_Chip-Seq_TH2_Human | 1.22835382 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22237828 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 1.21077143 |
| 81 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.20969769 |
| 82 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20479895 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19893584 |
| 84 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18836707 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18504054 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17709136 |
| 87 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17527230 |
| 88 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.17415588 |
| 89 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.16617895 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15834651 |
| 91 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15448732 |
| 92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14983000 |
| 93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14967188 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14696173 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14421942 |
| 96 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.13504337 |
| 97 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12600024 |
| 98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11962534 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11918622 |
| 100 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11778687 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11734583 |
| 102 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.10677013 |
| 103 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10116657 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10106885 |
| 105 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09829415 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09016041 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08907799 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08750122 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07551197 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07341871 |
| 111 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.07322431 |
| 112 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.07112127 |
| 113 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06842350 |
| 114 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06754603 |
| 115 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06393488 |
| 116 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06195424 |
| 117 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05354388 |
| 118 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05354388 |
| 119 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.04608123 |
| 120 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04274930 |
| 121 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04060797 |
| 122 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.03950061 |
| 123 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.00869532 |
| 124 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00863349 |
| 125 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00822404 |
| 126 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00524972 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 0.99936471 |
| 128 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98092590 |
| 129 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.97619214 |
| 130 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97102812 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96561438 |
| 132 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96557495 |
| 133 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94266128 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93393401 |
| 135 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91818505 |
| 136 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91320857 |
| 137 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90515947 |
| 138 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89861491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 2.67049874 |
| 2 | MP0005451_abnormal_body_composition | 2.65276499 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.60123780 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.44476014 |
| 5 | MP0005360_urolithiasis | 2.42672612 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.32019607 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.26402182 |
| 8 | MP0009840_abnormal_foam_cell | 2.01065046 |
| 9 | MP0001835_abnormal_antigen_presentation | 1.99335145 |
| 10 | MP0001853_heart_inflammation | 1.95983161 |
| 11 | MP0003172_abnormal_lysosome_physiology | 1.89301533 |
| 12 | MP0009785_altered_susceptibility_to | 1.88390061 |
| 13 | MP0008260_abnormal_autophagy | 1.87585441 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 1.86053292 |
| 15 | MP0003303_peritoneal_inflammation | 1.84832018 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 1.80023068 |
| 17 | MP0003724_increased_susceptibility_to | 1.71992582 |
| 18 | MP0003075_altered_response_to | 1.70307965 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.69700771 |
| 20 | MP0000685_abnormal_immune_system | 1.66431160 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 1.62747595 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.61891089 |
| 23 | MP0002396_abnormal_hematopoietic_system | 1.61003466 |
| 24 | MP0005365_abnormal_bile_salt | 1.60830004 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.59667238 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.59667238 |
| 27 | MP0005083_abnormal_biliary_tract | 1.56423765 |
| 28 | MP0005023_abnormal_wound_healing | 1.53198876 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.47980472 |
| 30 | MP0002405_respiratory_system_inflammati | 1.47225252 |
| 31 | MP0003186_abnormal_redox_activity | 1.47016698 |
| 32 | * MP0005025_abnormal_response_to | 1.46919143 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.46753518 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.46705338 |
| 35 | MP0002419_abnormal_innate_immunity | 1.43534209 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.41975220 |
| 37 | MP0008004_abnormal_stomach_pH | 1.41942104 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.41402356 |
| 39 | MP0004947_skin_inflammation | 1.39584031 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.39314744 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.38463752 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.35286754 |
| 43 | MP0005166_decreased_susceptibility_to | 1.34032761 |
| 44 | MP0001790_abnormal_immune_system | 1.33831188 |
| 45 | MP0005387_immune_system_phenotype | 1.33831188 |
| 46 | MP0008438_abnormal_cutaneous_collagen | 1.33610102 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.32219955 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.31832533 |
| 49 | MP0001800_abnormal_humoral_immune | 1.31370981 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.29052349 |
| 51 | MP0000343_altered_response_to | 1.27382882 |
| 52 | MP0005275_abnormal_skin_tensile | 1.26980818 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.26779458 |
| 54 | MP0003279_aneurysm | 1.26354721 |
| 55 | MP0000604_amyloidosis | 1.24803396 |
| 56 | MP0005310_abnormal_salivary_gland | 1.24396417 |
| 57 | MP0000858_altered_metastatic_potential | 1.20992165 |
| 58 | MP0000609_abnormal_liver_physiology | 1.20230558 |
| 59 | MP0002723_abnormal_immune_serum | 1.19896373 |
| 60 | MP0008469_abnormal_protein_level | 1.16734844 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.16321266 |
| 62 | MP0010329_abnormal_lipoprotein_level | 1.16293020 |
| 63 | MP0002060_abnormal_skin_morphology | 1.14878142 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.14775737 |
| 65 | MP0009278_abnormal_bone_marrow | 1.14019631 |
| 66 | MP0009764_decreased_sensitivity_to | 1.13633651 |
| 67 | MP0002166_altered_tumor_susceptibility | 1.13570087 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 1.12339022 |
| 69 | MP0000490_abnormal_crypts_of | 1.11705114 |
| 70 | MP0003091_abnormal_cell_migration | 1.11654033 |
| 71 | MP0006054_spinal_hemorrhage | 1.11169089 |
| 72 | MP0002933_joint_inflammation | 1.10701408 |
| 73 | MP0005164_abnormal_response_to | 1.10053580 |
| 74 | MP0005671_abnormal_response_to | 1.09690855 |
| 75 | MP0003252_abnormal_bile_duct | 1.09114575 |
| 76 | MP0001663_abnormal_digestive_system | 1.08794305 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 1.08346675 |
| 78 | * MP0002420_abnormal_adaptive_immunity | 1.08321949 |
| 79 | MP0002254_reproductive_system_inflammat | 1.08054388 |
| 80 | * MP0001819_abnormal_immune_cell | 1.07900364 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 1.07473576 |
| 82 | MP0003693_abnormal_embryo_hatching | 1.06450153 |
| 83 | MP0002132_abnormal_respiratory_system | 1.05272421 |
| 84 | MP0002398_abnormal_bone_marrow | 1.03972124 |
| 85 | MP0000689_abnormal_spleen_morphology | 1.03724595 |
| 86 | MP0002722_abnormal_immune_system | 1.01350951 |
| 87 | MP0010368_abnormal_lymphatic_system | 1.00756841 |
| 88 | MP0001243_abnormal_dermal_layer | 1.00112183 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 1.00090094 |
| 90 | MP0001542_abnormal_bone_strength | 0.99991769 |
| 91 | MP0001666_abnormal_nutrient_absorption | 0.98415429 |
| 92 | MP0001851_eye_inflammation | 0.98358337 |
| 93 | MP0001873_stomach_inflammation | 0.97473964 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.96771530 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.95415560 |
| 96 | MP0006082_CNS_inflammation | 0.95104546 |
| 97 | MP0002006_tumorigenesis | 0.95102446 |
| 98 | MP0003448_altered_tumor_morphology | 0.94143866 |
| 99 | MP0000716_abnormal_immune_system | 0.92898411 |
| 100 | MP0000598_abnormal_liver_morphology | 0.90858203 |
| 101 | MP0002429_abnormal_blood_cell | 0.90446978 |
| 102 | MP0004883_abnormal_blood_vessel | 0.88516786 |
| 103 | MP0003828_pulmonary_edema | 0.88216401 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.87813199 |
| 105 | * MP0009763_increased_sensitivity_to | 0.87026836 |
| 106 | MP0003866_abnormal_defecation | 0.86773144 |
| 107 | MP0002796_impaired_skin_barrier | 0.86120606 |
| 108 | MP0005390_skeleton_phenotype | 0.83784069 |
| 109 | MP0000703_abnormal_thymus_morphology | 0.83477361 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.82943693 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.82643505 |
| 112 | MP0005501_abnormal_skin_physiology | 0.80322035 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.79474999 |
| 114 | MP0004510_myositis | 0.77938625 |
| 115 | MP0009931_abnormal_skin_appearance | 0.77863179 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.77226706 |
| 117 | MP0005670_abnormal_white_adipose | 0.76953710 |
| 118 | MP0005165_increased_susceptibility_to | 0.76782902 |
| 119 | MP0003795_abnormal_bone_structure | 0.76655311 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.75707608 |
| 121 | MP0000749_muscle_degeneration | 0.75167192 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.74616418 |
| 123 | MP0000249_abnormal_blood_vessel | 0.74229618 |
| 124 | MP0008874_decreased_physiological_sensi | 0.71023853 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.69667344 |
| 126 | MP0005381_digestive/alimentary_phenotyp | 0.69057931 |
| 127 | MP0003690_abnormal_glial_cell | 0.68965006 |
| 128 | MP0003045_fibrosis | 0.68738531 |
| 129 | MP0004858_abnormal_nervous_system | 0.68260852 |
| 130 | MP0003329_amyloid_beta_deposits | 0.66485618 |
| 131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66408212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.31345618 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.31345618 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.31345618 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 3.60811098 |
| 5 | Optic neuritis (HP:0100653) | 3.60811098 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.26636179 |
| 7 | Dysostosis multiplex (HP:0000943) | 3.13128126 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.01516633 |
| 9 | Purpura (HP:0000979) | 2.99021138 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99005285 |
| 11 | Obstructive lung disease (HP:0006536) | 2.99005285 |
| 12 | Loss of speech (HP:0002371) | 2.97620154 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.96110639 |
| 14 | Increased connective tissue (HP:0009025) | 2.78016983 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.70441240 |
| 16 | Increased IgE level (HP:0003212) | 2.67372099 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 2.66845887 |
| 18 | Myocardial infarction (HP:0001658) | 2.65920954 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 2.65429106 |
| 20 | Xanthomatosis (HP:0000991) | 2.63063014 |
| 21 | Pustule (HP:0200039) | 2.62363782 |
| 22 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.61889453 |
| 23 | Vasculitis (HP:0002633) | 2.61773145 |
| 24 | Amyloidosis (HP:0011034) | 2.61477172 |
| 25 | Recurrent skin infections (HP:0001581) | 2.59978398 |
| 26 | Ulnar deviation of the wrist (HP:0003049) | 2.57760930 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.57205408 |
| 28 | Peritonitis (HP:0002586) | 2.55678928 |
| 29 | Gingivitis (HP:0000230) | 2.55674489 |
| 30 | Meningitis (HP:0001287) | 2.55548863 |
| 31 | Pulmonary infiltrates (HP:0002113) | 2.55522954 |
| 32 | Recurrent abscess formation (HP:0002722) | 2.50885058 |
| 33 | Cellulitis (HP:0100658) | 2.50626980 |
| 34 | Deep venous thrombosis (HP:0002625) | 2.49087137 |
| 35 | Recurrent viral infections (HP:0004429) | 2.48504147 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.47998629 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.47294042 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.46543072 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.46543072 |
| 40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.46543072 |
| 41 | Thrombocytosis (HP:0001894) | 2.46332581 |
| 42 | Increased IgM level (HP:0003496) | 2.44634916 |
| 43 | Nemaline bodies (HP:0003798) | 2.42740904 |
| 44 | Increased serum ferritin (HP:0003281) | 2.40019783 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.39704805 |
| 46 | Keratoconjunctivitis (HP:0001096) | 2.34843132 |
| 47 | Encephalitis (HP:0002383) | 2.32964975 |
| 48 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.32444850 |
| 49 | Type 1 muscle fiber predominance (HP:0003803) | 2.30846888 |
| 50 | Episodic fever (HP:0001954) | 2.30789664 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.29283846 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.28432985 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28432985 |
| 54 | Abnormality of iron homeostasis (HP:0011031) | 2.27317510 |
| 55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.23245192 |
| 56 | Distal lower limb muscle weakness (HP:0009053) | 2.23211551 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.22299684 |
| 58 | Myositis (HP:0100614) | 2.21442518 |
| 59 | Premature rupture of membranes (HP:0001788) | 2.21292515 |
| 60 | Polycythemia (HP:0001901) | 2.21186578 |
| 61 | Rhabdomyolysis (HP:0003201) | 2.17536611 |
| 62 | Hypochromic anemia (HP:0001931) | 2.16529015 |
| 63 | Hypoalphalipoproteinemia (HP:0003233) | 2.15299313 |
| 64 | Right ventricular cardiomyopathy (HP:0011663) | 2.14837923 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.13341661 |
| 66 | Epistaxis (HP:0000421) | 2.13271745 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.12647038 |
| 68 | Intrahepatic cholestasis (HP:0001406) | 2.12073653 |
| 69 | Microcytic anemia (HP:0001935) | 2.11913584 |
| 70 | T lymphocytopenia (HP:0005403) | 2.11791864 |
| 71 | Esophageal varix (HP:0002040) | 2.11166536 |
| 72 | Petechiae (HP:0000967) | 2.08987099 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.08805524 |
| 74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08805524 |
| 75 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.07636182 |
| 76 | Abnormality of the common coagulation pathway (HP:0010990) | 2.06254787 |
| 77 | Anorexia (HP:0002039) | 2.05924152 |
| 78 | Hypobetalipoproteinemia (HP:0003563) | 2.05775783 |
| 79 | Leukocytosis (HP:0001974) | 2.05588055 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.04604223 |
| 81 | Joint hemorrhage (HP:0005261) | 2.04204212 |
| 82 | Vertebral compression fractures (HP:0002953) | 2.04159582 |
| 83 | Abnormal platelet function (HP:0011869) | 2.03983734 |
| 84 | Impaired platelet aggregation (HP:0003540) | 2.03983734 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.03919519 |
| 86 | Hypolipoproteinemia (HP:0010981) | 2.03784584 |
| 87 | Chest pain (HP:0100749) | 2.03555244 |
| 88 | Gingival bleeding (HP:0000225) | 2.01893678 |
| 89 | Hemoptysis (HP:0002105) | 2.01048992 |
| 90 | Abnormality of T cell number (HP:0011839) | 2.00527004 |
| 91 | Autoimmune hemolytic anemia (HP:0001890) | 1.99764277 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 1.99663966 |
| 93 | Disinhibition (HP:0000734) | 1.98323467 |
| 94 | Increased density of long bones (HP:0006392) | 1.98141474 |
| 95 | Gangrene (HP:0100758) | 1.97919295 |
| 96 | Distal arthrogryposis (HP:0005684) | 1.96761874 |
| 97 | Inflammation of the large intestine (HP:0002037) | 1.96446537 |
| 98 | Prolonged partial thromboplastin time (HP:0003645) | 1.96329985 |
| 99 | Nonimmune hydrops fetalis (HP:0001790) | 1.95628824 |
| 100 | Cupped ribs (HP:0000887) | 1.95617828 |
| 101 | Gastrointestinal inflammation (HP:0004386) | 1.94894235 |
| 102 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94473107 |
| 103 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94253021 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94253021 |
| 105 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.93803439 |
| 106 | Polyneuropathy (HP:0001271) | 1.93491922 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.93369215 |
| 108 | Abnormal platelet volume (HP:0011876) | 1.93056496 |
| 109 | Nuclear cataract (HP:0100018) | 1.92731807 |
| 110 | Abnormality of complement system (HP:0005339) | 1.92413010 |
| 111 | Increased mean platelet volume (HP:0011877) | 1.91769257 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 1.90313246 |
| 113 | Stomatitis (HP:0010280) | 1.89288382 |
| 114 | Orchitis (HP:0100796) | 1.89159041 |
| 115 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.88809840 |
| 116 | Hypertensive crisis (HP:0100735) | 1.88208312 |
| 117 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.87974478 |
| 118 | Nausea (HP:0002018) | 1.87915193 |
| 119 | Spontaneous hematomas (HP:0007420) | 1.87583823 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 1.87545050 |
| 121 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87487006 |
| 122 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87341587 |
| 123 | Glomerulopathy (HP:0100820) | 1.86141525 |
| 124 | Systemic lupus erythematosus (HP:0002725) | 1.86136730 |
| 125 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.84503598 |
| 126 | Progressive neurologic deterioration (HP:0002344) | 1.84048532 |
| 127 | Recurrent fungal infections (HP:0002841) | 1.83746388 |
| 128 | Hypertriglyceridemia (HP:0002155) | 1.83605280 |
| 129 | Abnormality of the nasal mucosa (HP:0000433) | 1.83600110 |
| 130 | Osteomyelitis (HP:0002754) | 1.82896654 |
| 131 | Abnormality of T cell physiology (HP:0011840) | 1.82175138 |
| 132 | Myopathic facies (HP:0002058) | 1.82150139 |
| 133 | Abnormality of the pericardium (HP:0001697) | 1.80842945 |
| 134 | Thrombophlebitis (HP:0004418) | 1.80492023 |
| 135 | Arterial thrombosis (HP:0004420) | 1.80187280 |
| 136 | Flat acetabular roof (HP:0003180) | 1.80035273 |
| 137 | Exercise-induced muscle cramps (HP:0003710) | 1.79216650 |
| 138 | Abnormality of macrophages (HP:0004311) | 1.78988331 |
| 139 | Menorrhagia (HP:0000132) | 1.78879226 |
| 140 | Axonal loss (HP:0003447) | 1.78784046 |
| 141 | Abnormal number of erythroid precursors (HP:0012131) | 1.78758112 |
| 142 | Hyperammonemia (HP:0001987) | 1.77903000 |
| 143 | Urticaria (HP:0001025) | 1.77884445 |
| 144 | Beaking of vertebral bodies (HP:0004568) | 1.77152996 |
| 145 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.76896239 |
| 146 | Myoglobinuria (HP:0002913) | 1.76426094 |
| 147 | Alopecia of scalp (HP:0002293) | 1.76343678 |
| 148 | Hypercholesterolemia (HP:0003124) | 1.75128623 |
| 149 | Difficulty climbing stairs (HP:0003551) | 1.75068693 |
| 150 | Multiple enchondromatosis (HP:0005701) | 1.75057774 |
| 151 | Hyperlipoproteinemia (HP:0010980) | 1.75048211 |
| 152 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.72540288 |
| 153 | Mediastinal lymphadenopathy (HP:0100721) | 1.72244876 |
| 154 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71449244 |
| 155 | Cervical subluxation (HP:0003308) | 1.69944836 |
| 156 | Entropion (HP:0000621) | 1.67009529 |
| 157 | Calcaneovalgus deformity (HP:0001848) | 1.64232801 |
| 158 | Vacuolated lymphocytes (HP:0001922) | 1.63959816 |
| 159 | Abnormality of the prostate (HP:0008775) | 1.62958117 |
| 160 | Abnormality of the intrinsic pathway (HP:0010989) | 1.62521687 |
| 161 | Abnormality of the calcaneus (HP:0008364) | 1.62349869 |
| 162 | Reduced antithrombin III activity (HP:0001976) | 1.61477519 |
| 163 | Abnormal foot bone ossification (HP:0010675) | 1.61019508 |
| 164 | Prolonged bleeding time (HP:0003010) | 1.60043370 |
| 165 | Ileus (HP:0002595) | 1.59984797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIM2 | 3.55044587 |
| 2 | PRPF4B | 3.28184791 |
| 3 | RIPK4 | 3.22054330 |
| 4 | NME2 | 3.01228746 |
| 5 | ERN1 | 2.85918888 |
| 6 | TRIB3 | 2.73179253 |
| 7 | MAP4K1 | 2.65213399 |
| 8 | TBK1 | 2.21208186 |
| 9 | MAP3K14 | 2.18288475 |
| 10 | TTN | 2.10095319 |
| 11 | RPS6KA4 | 2.09526918 |
| 12 | PKN2 | 2.05971690 |
| 13 | ZAP70 | 1.86105468 |
| 14 | STK10 | 1.83836505 |
| 15 | JAK3 | 1.78749483 |
| 16 | FGR | 1.67425211 |
| 17 | IKBKB | 1.66020705 |
| 18 | TGFBR2 | 1.58317299 |
| 19 | GRK7 | 1.57266132 |
| 20 | TYK2 | 1.56811896 |
| 21 | KDR | 1.56656606 |
| 22 | FLT3 | 1.51589164 |
| 23 | RIPK1 | 1.51481623 |
| 24 | BCKDK | 1.49492405 |
| 25 | TEC | 1.49418964 |
| 26 | KIT | 1.46217484 |
| 27 | FES | 1.38880259 |
| 28 | TXK | 1.38321891 |
| 29 | MAP3K13 | 1.37775497 |
| 30 | PIM1 | 1.36347524 |
| 31 | MAP3K10 | 1.35533774 |
| 32 | LRRK2 | 1.34817208 |
| 33 | EEF2K | 1.34474499 |
| 34 | PIK3CG | 1.33709667 |
| 35 | IKBKE | 1.32572187 |
| 36 | BTK | 1.30890142 |
| 37 | TRPM7 | 1.29864681 |
| 38 | FGFR4 | 1.28294900 |
| 39 | MOS | 1.27612042 |
| 40 | TESK1 | 1.25233568 |
| 41 | * MAP2K3 | 1.23390856 |
| 42 | SMG1 | 1.22781299 |
| 43 | EPHA2 | 1.22173534 |
| 44 | NEK9 | 1.21756928 |
| 45 | * MAP3K3 | 1.20123281 |
| 46 | MAPKAPK3 | 1.19990782 |
| 47 | CHUK | 1.19878645 |
| 48 | CDC42BPA | 1.14328930 |
| 49 | IRAK3 | 1.13727427 |
| 50 | DDR2 | 1.10891502 |
| 51 | RPS6KB2 | 1.10802104 |
| 52 | TNK2 | 1.10584718 |
| 53 | * MAP3K1 | 1.08326810 |
| 54 | SIK3 | 1.07364284 |
| 55 | IRAK4 | 1.04491769 |
| 56 | MST4 | 1.03327782 |
| 57 | BLK | 1.02667862 |
| 58 | MARK3 | 1.01222585 |
| 59 | TGFBR1 | 1.01010752 |
| 60 | ITK | 1.00256320 |
| 61 | IRAK2 | 0.99694556 |
| 62 | BMPR2 | 0.98802135 |
| 63 | PTK6 | 0.96664878 |
| 64 | CDK6 | 0.95712466 |
| 65 | SIK1 | 0.95230248 |
| 66 | ICK | 0.94514161 |
| 67 | TESK2 | 0.93370323 |
| 68 | EIF2AK1 | 0.92461848 |
| 69 | PRKD2 | 0.92439093 |
| 70 | CSK | 0.91244109 |
| 71 | WEE1 | 0.90957991 |
| 72 | MST1R | 0.90889434 |
| 73 | OBSCN | 0.88197486 |
| 74 | IRAK1 | 0.88100774 |
| 75 | PAK4 | 0.87051904 |
| 76 | NLK | 0.85428837 |
| 77 | PRKG2 | 0.81708862 |
| 78 | BRSK2 | 0.78043584 |
| 79 | * TAOK2 | 0.77341548 |
| 80 | ABL2 | 0.76759213 |
| 81 | MARK2 | 0.75214325 |
| 82 | EPHB1 | 0.74825443 |
| 83 | ARAF | 0.74268351 |
| 84 | KSR2 | 0.73520401 |
| 85 | HIPK2 | 0.73204824 |
| 86 | PDPK1 | 0.72393319 |
| 87 | HCK | 0.71986055 |
| 88 | BUB1 | 0.70757295 |
| 89 | CDK4 | 0.70359394 |
| 90 | MAPK11 | 0.68539946 |
| 91 | MAP3K7 | 0.64895889 |
| 92 | JAK2 | 0.64416571 |
| 93 | CDK12 | 0.63945925 |
| 94 | TIE1 | 0.63943375 |
| 95 | MAPKAPK2 | 0.63564416 |
| 96 | ZAK | 0.62210903 |
| 97 | * MAP3K11 | 0.62183831 |
| 98 | RPS6KL1 | 0.62020612 |
| 99 | PDK1 | 0.61800325 |
| 100 | CSF1R | 0.60982710 |
| 101 | MAPK12 | 0.60622355 |
| 102 | * MAP3K8 | 0.59895678 |
| 103 | PAK2 | 0.59478316 |
| 104 | TAOK3 | 0.58174407 |
| 105 | CDK7 | 0.56394038 |
| 106 | SYK | 0.56223060 |
| 107 | JAK1 | 0.56114967 |
| 108 | LCK | 0.55170517 |
| 109 | LYN | 0.53827654 |
| 110 | STK4 | 0.53387724 |
| 111 | ILK | 0.52554555 |
| 112 | PTK2B | 0.51421464 |
| 113 | STK24 | 0.51369481 |
| 114 | GRK6 | 0.51137301 |
| 115 | RPS6KA6 | 0.50846009 |
| 116 | MAP2K6 | 0.50405203 |
| 117 | MAP2K2 | 0.49777098 |
| 118 | EPHA3 | 0.49116392 |
| 119 | AURKB | 0.47839299 |
| 120 | MATK | 0.46503515 |
| 121 | MAP3K6 | 0.45907957 |
| 122 | BMX | 0.44818328 |
| 123 | SCYL2 | 0.43965432 |
| 124 | NEK2 | 0.43167610 |
| 125 | EIF2AK3 | 0.42599620 |
| 126 | MAPK7 | 0.41997569 |
| 127 | MAPK4 | 0.40596551 |
| 128 | NEK1 | 0.39783768 |
| 129 | ABL1 | 0.39050419 |
| 130 | CLK1 | 0.38126602 |
| 131 | DYRK1B | 0.37949814 |
| 132 | MYLK | 0.37683206 |
| 133 | RPS6KC1 | 0.35506977 |
| 134 | RPS6KA2 | 0.34630979 |
| 135 | SGK3 | 0.33098382 |
| 136 | FYN | 0.30271134 |
| 137 | STK38 | 0.30091138 |
| 138 | DYRK3 | 0.29472438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.30015511 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20818439 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80026898 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 1.73030189 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72558412 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.68515533 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.68486288 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67427536 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 1.64870379 |
| 10 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64780278 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61840301 |
| 12 | Salmonella infection_Homo sapiens_hsa05132 | 1.61344302 |
| 13 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.59224682 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.56907096 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55208813 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54599787 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54513868 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54393944 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.52277052 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48956889 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48209569 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44081266 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43261588 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43019766 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42226981 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38803712 |
| 27 | Ribosome_Homo sapiens_hsa03010 | 1.37775668 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.35743475 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35129260 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34404305 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30825236 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29449207 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28712743 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25572494 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22948041 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22551580 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.22023931 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21317376 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.15516618 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14084821 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13758498 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.13654411 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11452278 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 1.11142505 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10176359 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.10081957 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07591740 |
| 48 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06291052 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06005311 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02924014 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02229825 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01271211 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01065004 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00786022 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.00783647 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99943420 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98960148 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.98929275 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.98892581 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97494944 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97292572 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97091270 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96446137 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96025419 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.95749192 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.95548725 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94629606 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93532693 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93281662 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93103138 |
| 71 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.92808021 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.91425256 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91282431 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91094023 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90494714 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90118699 |
| 77 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89362195 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88481114 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.88364238 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.88059046 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87924087 |
| 82 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87794193 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87776670 |
| 84 | * TNF signaling pathway_Homo sapiens_hsa04668 | 0.87598114 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87114344 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.86908359 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.86593075 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85012811 |
| 89 | Base excision repair_Homo sapiens_hsa03410 | 0.84979981 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83140301 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80720255 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.79724877 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78747641 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77432542 |
| 95 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.76098974 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75821892 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75632360 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74199960 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74196052 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74007890 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73500105 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72945855 |
| 103 | Asthma_Homo sapiens_hsa05310 | 0.72700930 |
| 104 | * Influenza A_Homo sapiens_hsa05164 | 0.71999970 |
| 105 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71698042 |
| 106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70558710 |
| 107 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70100178 |
| 108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69370294 |
| 109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69343161 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68286189 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.67867413 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.67663895 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67094231 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66855296 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66479804 |
| 116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65037872 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64810393 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64413566 |
| 119 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64124293 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63167029 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62794663 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.62366027 |
| 123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61144765 |
| 124 | Tuberculosis_Homo sapiens_hsa05152 | 0.60792758 |
| 125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59817021 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.59353195 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58468148 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56863471 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56128645 |
| 130 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53896056 |
| 131 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53068532 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52611127 |
| 133 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51823541 |
| 134 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51202347 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51074309 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.50984972 |
| 137 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50738637 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47725476 |
| 139 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41779322 |
| 140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41067827 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39668029 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35707911 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35245768 |
| 144 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34777230 |
| 145 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33845614 |
| 146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33716855 |
| 147 | Prostate cancer_Homo sapiens_hsa05215 | 0.32370373 |
| 148 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32196282 |
| 149 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30580226 |
| 150 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29700497 |

